Evidence map›Paper›PMID 25339738›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Effects of HIV-1 Tat on enteric neuropathogenesis.

Joy Ngwainmbi, Dipanjana D De, Tricia H Smith, Nazira El-Hage, Sylvia Fitting, Minho Kang, William L Dewey, Kurt F Hauser, Hamid I Akbarali

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Epigenetic mechanisms of HIV and opioid-induced neuropathology: Potential therapies and interventions.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. The Gain-of-Function R222S Variant inFrontiers in neurology · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. [The Journal of pharmacology and experimental therapeutics · 2020
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Joy NgwainmbiDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298.
Dipanjana D DeDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298.
Tricia H SmithDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298.
Nazira El-HageDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298.
Sylvia FittingDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298.ORCID http://orcid.org/0000-0002-8906-3133
Minho KangDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298.ORCID http://orcid.org/0000-0002-1825-7141
William L DeweyDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298.
Kurt F HauserDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298.ORCID http://orcid.org/0000-0001-7886-0332
Hamid I AkbaraliDepartment of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298 hiakbarali@vcu.edu.
Virginia Commonwealth University · US

Funding

TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
VCU Center for Drug Addiction ResearchP30DA033934 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI YAN ZHANG · 2014 to 2026
$13.8M
Virginia Commonwealth University Initiative for Maximizing Student DevelopmentR25GM090084 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI AKBARALI, HAMID I, LLOYD, JOYCE A. · 2010 to 2022
$5.2M
Mechanisms of Opiate Drug-HIV-Induced NeurodegenerationR01DA018633 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI HAUSER, KURT F · 2005 to 2021
$4.4M
Ionic currents in gastrointestinal smooth muscleR01DK046367 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI AKBARALI, HAMID I · 1999 to 2014
$3.8M
Opioid tolerance and bowel dysfunctionR01DA024009 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI AKBARALI, HAMID I, DEWEY, WILLIAM L. · 2009 to 2015
$2.1M
Neuron-Glia Mechanisms & Interactions Underlying Opioid Abuse-HIV-1 ComorbidityK02DA027374 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI HAUSER, KURT F · 2009 to 2018
$1.3M
Opiate drug abuse & HIV-induced excitotoxicity in striatal neuronsK99DA033878 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI FITTING, SYLVIA · 2013 to 2014
$220k
Modulation of sodium channels by HIV-1Tat in enteric neuronsF31NS087952 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI GUEDIA, JOY K · 2014 to 2015
$40k
IONIC CURRENTS IN GASTROINTESTINAL MUSCULARIS MUCOSAR29DK046367 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI AKBARALI, HAMID I · 1993 to 1998
–
NIDA NIH HHS K02 DA027374NIDA NIH HHS K99 DA033878NIDA NIH HHS P30 DA033934NIDA NIH HHS R01 DA018633NIDA NIH HHS R01 DA024009NIDA NIH HHS T32 DA007027NIDDK NIH HHS DK046367NIDDK NIH HHS R01 DK046367NIGMS NIH HHS R25 GM090084NINDS NIH HHS F31 NS087952
6 · The paper itself

Abstract

The gastrointestinal (GI) tract presents a major site of immune modulation by HIV, resulting in significant morbidity. Most GI processes affected during HIV infection are regulated by the enteric nervous system. HIV has been identified in GI histologic specimens in up to 40% of patients, and the presence of viral proteins, including the trans-activator of transcription (Tat), has been reported in the gut indicating that HIV itself may be an indirect gut pathogen. Little is known of how Tat affects the enteric nervous system. Here we investigated the effects of the Tat protein on enteric neuronal excitability, proinflammatory cytokine release, and its overall effect on GI motility. Direct application of Tat (100 nm) increased the number of action potentials and reduced the threshold for action potential initiation in isolated myenteric neurons. This effect persisted in neurons pretreated with Tat for 3 d (19 of 20) and in neurons isolated from Tat(+) (Tat-expressing) transgenic mice. Tat increased sodium channel isoforms Nav1.7 and Nav1.8 levels. This increase was accompanied by an increase in sodium current density and a leftward shift in the sodium channel activation voltage. RANTES, IL-6, and IL-1β, but not TNF-α, were enhanced by Tat. Intestinal transit and cecal water content were also significantly higher in Tat(+) transgenic mice than Tat(-) littermates (controls). Together, these findings show that Tat has a direct and persistent effect on enteric neuronal excitability, and together with its effect on proinflammatory cytokines, regulates gut motility, thereby contributing to GI dysmotilities reported in HIV patients.

Indexed as

HIV-1Action PotentialsAnimalsEnteric Nervous SystemFemaleGastrointestinal MotilityHumansIleumInflammation MediatorsMaleMiceMice, TransgenicNeuronsOrgan Culture TechniquesRats, Sprague-Dawleytat Gene Products, Human Immunodeficiency VirusInflammation Mediatorstat Gene Products, Human Immunodeficiency VirusAIDScytokinesHIVmyentericsodium channels

Identifiers

PMID25339738
PMCPMC4205550
OpenAlexW2044887735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.